Jade Nemeth
Medical · Houston, TXNPI 1255188041
Payments from drug & device makers
Across 128 payments — averaging $28.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$519
- ANI Pharmaceuticals, Inc.$489
- Mallinckrodt Hospital Products Inc.$453
- Pfizer$411
- Johnson & Johnson$388
- AstraZeneca$387
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,57497%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $519 |
| ANI Pharmaceuticals, Inc. | 6 | $489 |
| Mallinckrodt Hospital Products Inc. | 18 | $453 |
| Pfizer | 14 | $411 |
| Johnson & Johnson | 15 | $388 |
| AstraZeneca(2 entities) | 8 | $387 |
| UCB, Inc. | 9 | $196 |
| Saluda Medical Americas, Inc. | 1 | $146 |
| Novo Nordisk | 1 | $106 |
| Lilly USA, LLC | 1 | $99 |
| Janssen Scientific Affairs, LLC | 2 | $94 |
| Amgen | 5 | $86 |
| Boehringer Ingelheim | 3 | $57 |
| Biogen | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Novartis | 1 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| GSK | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$373
- ACTHAR$248
- SAPHNELO$230
- Evoke$146
How this compares
$3,673 in reported general payments places this provider in the 80th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 49 | $1,641 |
| MethotrexateMethotrexate Sodium | 53 | $1,214 |
| Gabapentin | 45 | $635 |
| Leflunomide | 14 | $591 |
| Celecoxib | 17 | $460 |
| Prednisone | 62 | $279 |
| Methylprednisolone | 26 | $278 |
| Folic Acid | 28 | $193 |
| Pregabalin | 11 | $177 |
| Tramadol Hcl | 30 | $165 |
| Duloxetine Hcl | 20 | $139 |
| Meloxicam | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Omni McCluneyHouston$18K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.